According to our latest market study on "Single-cell analysis Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Cell Type, Technique, Application, End User, and Geography," the market is expected to grow from US$ 3.18 billion in 2021 to US$ 8.20 billion by 2028; it is projected to grow at a CAGR of 14.5% from 2022 to 2028.
Malignant growth cases is one of the significant reasons for death across the world and its weight is set to winding. As per the Public Malignant growth Establishment, 1,806,590 new disease cases were accounted for in the US and 606,520 related passings (mortalities) were enlisted in 2020. As per World Wellbeing Association (WHO), around 10 million passings were brought about by disease in 2020 around the world. Global Organization for Exploration on Disease (IARC) expressed that by 2040, the worldwide weight of tumors is supposed to develop to 27.5 million new malignant growth cases and 16.3 million passings around the world. Developing conclusion and therapy looking for rate are probably going to empower the checking and the executives of malignant growth movement. Single-cell examination use robotized work processes with continuous checking of disease cells and think up original restorative procedures for clinical administration. This is supposed to prompt more effective and better investigation. Accordingly, expanding rate of disease will help Research and development exercises, further going about as one of the significant driving elements to the market.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPBT00002552/
In view of item, the single-cell examination market is bifurcated into instruments and consumables. In 2021, consumables represented the biggest portion of the single-cell examination market because of their maximum usage than instruments.
By strategy, the market is divided into stream cytometry, cutting edge sequencing, polymerase chain response, microscopy, mass spectrometry, and different methods. The cutting edge sequencing portion represented the biggest piece of the pie in 2021, and it is normal to rule the market over the estimate period attributable to expanding reception in genome planning program and mechanical progression in sequencing stage.
The end client fragment is additionally portioned into scholastic and examination labs, biotechnology and drug organizations, medical clinics and demonstrative research facilities, and cell banks and IVF focuses. The scholar and exploration research centers section represented the biggest piece of the pie in 2021, and proceeding with its strength in the market over the conjecture period is normal. An ascent in Research and development exercises combined with public-private subsidizing and developing number of scholastic and exploration labs offices are supposed to help the development of the single-cell examination market.
North America overwhelmed the single-cell examination market with ~42% piece of the pie in 2021. The market development in the district is significantly ascribed to expanding Research and development use and government financing, advanced medical services framework, developing drug and life science industry, and vital drives by noticeable players alongside the presence of these central parts in the area. In addition, rising mindfulness because of the great rate of disease sicknesses in the area has animated the development of single-cell examination market. Further, there has been a flood in Coronavirus related research projects, particularly after the episode, utilizing single-cell genome sequencing, thus driving business sector development. In this way, attributable to the previously mentioned factors, the single-cell examination market is supposed to observe huge development over the estimate period in North America.
Agilent Technologies; Beckman Coulter Inc.; Becton Dickinson & Company (BD); Bio-Rad Laboratories, Inc.; Fluidigm Corporation; GE Healthcare; Illumina, Inc.; Merck KGaA; Qiagen N.V.; and Thermo Fisher Scientific, Inc. are among the key players profiled during the study of the single-cell analysis market. Several other major companies were analyzed during this study to get a holistic view of the single-cell analysis market and its ecosystem.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Person: Sameer Joshi
Email Id: [email protected]